KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Encompass Health (EHC) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to 11.1%.

  • Encompass Health's EBITDA Margin fell 100400.0% to 0.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.22%, marking a year-over-year decrease of 33500.0%. This contributed to the annual value of 11.1% for FY2024, which is 14600.0% up from last year.
  • As of FY2024, Encompass Health's EBITDA Margin stood at 11.1%, which was up 14600.0% from 9.64% recorded in FY2023.
  • Over the past 5 years, Encompass Health's EBITDA Margin peaked at 12.88% during FY2021, and registered a low of 8.41% during FY2022.
  • Its 5-year average for EBITDA Margin is 10.48%, with a median of 10.34% in 2020.
  • Its EBITDA Margin has fluctuated over the past 5 years, first surged by 25400bps in 2021, then tumbled by -44700bps in 2022.
  • Annual analysis of 5 years shows Encompass Health's EBITDA Margin stood at 10.34% in 2020, then rose by 25bps to 12.88% in 2021, then tumbled by -35bps to 8.41% in 2022, then increased by 15bps to 9.64% in 2023, then increased by 15bps to 11.1% in 2024.
  • Its EBITDA Margin was 11.1% in FY2024, compared to 9.64% in FY2023 and 8.41% in FY2022.